A detailed history of Odey Asset Management Group LTD transactions in Provention Bio, Inc. stock. As of the latest transaction made, Odey Asset Management Group LTD holds 170,019 shares of PRVB stock, worth $0. This represents 1.36% of its overall portfolio holdings.

Number of Shares
170,019
Holding current value
$0
% of portfolio
1.36%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$6.7 - $24.21 $1.14 Million - $4.12 Million
170,019 New
170,019 $4.1 Million

Others Institutions Holding PRVB

# of Institutions
1
Shares Held
170K
Call Options Held
0
Put Options Held
0

About Provention Bio, Inc.


  • Ticker PRVB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 81,549,904
  • Description
  • Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...
More about PRVB
Track This Portfolio

Track Odey Asset Management Group LTD Portfolio

Follow Odey Asset Management Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Odey Asset Management Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Odey Asset Management Group LTD with notifications on news.